Bank Pictet & Cie (Asia) LTD Abb Vie Inc. Transaction History

Bank Pictet & Cie (Asia) LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $658,389 - $774,892	-8,535 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $190,267 - $211,517	-2,140 Reduced 20.05%	8,535 $807,000
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $958,401 - $1.13 Million	10,675 New	10,675 $989,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bank Pictet & Cie (Asia) LTD, based on Form 13F filings with the SEC.

Stay updated on Bank Pictet & Cie (Asia) LTD with notifications on news.